Meadowsweet — Benefits Deep Dive

Meadowsweet (Filipendula ulmaria, formerly Spiraea ulmaria) is the herb with the best story in the whole European herbal cabinet, and the story is usually told wrong. The -spir- in aspirin really does come from Spiraea, this plant's old genus — that etymology is genuine and worth knowing. But the plant does not contain aspirin. It contains salicylate glycosides and aromatic salicylates, not acetylsalicylic acid, and the acetyl group that Bayer added in 1897 is precisely what changes how the drug behaves in your stomach and your platelets. "Herbal aspirin" is not an exaggeration; it is a category error.

These four deep dives work through what follows from that. Why the etymology is real but the pharmacology is different. Why a salicylate plant was traditionally used for stomach complaints when aspirin famously causes them — and how far the proposed resolution actually goes. What the joint-pain and fever evidence amounts to, which is tradition plus animal data and essentially no controlled human trial of meadowsweet for any indication. And, most practically, who should not drink it: the salicylate-sensitive, people with aspirin-sensitive asthma, children and teenagers with a viral illness, and anyone on an anticoagulant. Each page labels its claims by evidence tier — randomised trial, preliminary animal or in-vitro, or traditional use only — because for this plant those three tiers point in noticeably different directions.

Meadowsweet, Salicylates and the Aspirin Story

The etymology is real: Spiraea gave aspirin its "-spir-". The chemistry is not what people assume. Meadowsweet holds salicylate glycosides, salicylaldehyde and methyl salicylate — never acetylsalicylic acid — and acetylation is what creates irreversible COX inhibition, lifelong platelet blockade and the classic gastric injury. Why "herbal aspirin" misleads in both directions, why the tea is no substitute for prescribed low-dose aspirin, and why nobody can tell you your dose.

Meadowsweet for Digestion and Stomach Comfort

Aspirin causes ulcers; meadowsweet was traditionally used to soothe them. The best content on this plant is the resolution of that paradox — non-acetylated salicylate that is a weak, reversible COX inhibitor, glycosides that pass the stomach intact, and a heavy load of ellagitannins and mucilage — supported by real animal gastroprotection data. Also the honest limit: that is a plausible mechanism with preclinical support, not a demonstrated human effect.

Meadowsweet for Joint Pain and Fever

Rheumatic pain and feverish colds are the plant's oldest indications, resting on centuries of European use plus positive but preliminary anti-inflammatory work in cells and rodents. What is missing is any adequate controlled human trial. German Commission E permitted it as supportive therapy for colds — a monograph built on tradition, not trial data. Includes a direct comparison with willow bark, which has the weaker story and the better evidence.

Meadowsweet Safety: Who Should Avoid It

The practically important page. Because it delivers salicylates: avoid in salicylate sensitivity and in aspirin-sensitive asthma, which can be severe; avoid in children and teenagers with viral illness given the Reye's syndrome association; caution with anticoagulants and antiplatelets, in active peptic ulcer disease despite the tradition, and in pregnancy. Plus the coumarin myth corrected, and why an unstandardised dose cuts both ways.

What Meadowsweet Is
The Four Deep Dives
Evidence at a Glance
Key Research: History and Etymology
Key Research: Chemistry and Salicylates
Key Research: Gastroprotection and Digestion
Key Research: Inflammation, Pain and Antioxidants
Key Research: Salicylate Safety
External Resources
Connections

What Meadowsweet Is

A tall perennial of damp European meadows, ditches and riverbanks, in the rose family (Rosaceae), carrying flat sprays of tiny creamy flowers that smell of wintergreen and almond. Old English names include queen of the meadow, bridewort and meadwort — the last a reminder that the flowers were used to flavour mead. The parts used medicinally are the flowering tops: flowers and upper leaves, gathered in summer and dried.

Its chemistry divides into three groups that matter differently:

Salicylates — the phenolic glycosides monotropitin (gaultherin) and spiraein, plus the volatile salicylaldehyde and methyl salicylate that produce the scent, and a little free salicylic acid. These are stored sugar-bound and released mainly by gut bacteria, which makes onset slow and the delivered dose dependent on your own microbiome.
Tannins — ellagitannins in quantity, including rugosin-type compounds. By weight, meadowsweet is more a tannin herb than a salicylate herb, and the tannins are the traditional basis for its astringent, stomach-settling reputation.
Flavonoids — notably spiraeoside (quercetin 4′-O-glucoside, named for the plant), with quercetin, hyperoside, rutin and kaempferol glycosides. If the herb has any anti-inflammatory effect in people, these are at least as plausible a contributor as the salicylates.

The full topic overview, including the plant's history and the Hoffmann–Eichengrün question, sits on the main Meadowsweet page.

The Four Deep Dives

Meadowsweet, Salicylates and the Aspirin Story — the true etymology, the two-plant history shared with willow, the glycoside pharmacology, what acetylation actually does, and why the herb is not a substitute for prescribed antiplatelet aspirin.
Meadowsweet for Digestion and Stomach Comfort — the paradox and its proposed resolution, the dual mechanism of NSAID gastric injury, tannins and mucilage, the animal gastroprotection data, and the human evidence gap.
Meadowsweet for Joint Pain and Fever — traditional indications, the salicylate and polyphenol rationales, the preclinical data, what a Commission E monograph does and does not mean, and how it compares with willow bark.
Meadowsweet Safety: Who Should Avoid It — the practical page: salicylate sensitivity, aspirin-exacerbated respiratory disease, Reye's syndrome, anticoagulants, ulcers, pregnancy, and the unstandardised dose.

Evidence at a Glance

Sorting meadowsweet's claims by what they actually rest on, because the tiers differ dramatically and most write-ups blend them:

Settled chemistry and history. That meadowsweet was Spiraea ulmaria; that spiraeic acid gave aspirin its "-spir-"; that the plant contains salicylate glycosides and aromatic salicylates but no acetylsalicylic acid. Not health claims at all — documented fact.
Established pharmacology, applied by inference. That acetylation is what produces irreversible COX inhibition and lifelong platelet blockade; that non-acetylated salicylate drugs such as salsalate are less gastrotoxic and barely antiplatelet. Solid for the drugs; extrapolated to the herb.
Preliminary — animal and in vitro. Gastroprotection in an experimental gastric-lesion model; anti-inflammatory activity in cells and rodents; analgesic effects in animal models; retained activity of gut-generated metabolites; high antioxidant capacity; antimicrobial activity of extracts and volatile oil.
Traditional use only. Fever, rheumatic and joint pain, heartburn, gastritis, nausea, mild diarrhoea. Centuries of consistent European use and a German Commission E monograph permitting it as supportive therapy for colds — a monograph based on documented tradition and expert judgement rather than trials.
Absent. Adequate controlled human trials of meadowsweet for any indication. Not negative trials — effectively no trials. The research sections below include searches that let you verify that for yourself.

That profile makes meadowsweet an interesting and under-studied plant rather than a proven remedy, and it is a much more useful thing to know than a confident claim you would have to distrust.

Key Research: History and Etymology

All citations on this site link to PubMed topic or title searches rather than fixed records, so links keep working and you can see the surrounding literature.

Sneader W. "The discovery of aspirin: a reappraisal." BMJ, 2000. The influential argument from Bayer's laboratory record that Arthur Eichengrün, not Felix Hoffmann, directed the acetylation work. Tier: historical scholarship. Search PubMed
Desborough MJR, Keeling DM. "The aspirin story — from willow to wonder drug." British Journal of Haematology, 2017. Traces salicylates through both willow and meadowsweet, which is the accurate two-plant version of the story. Tier: narrative review. Search PubMed
Wood JN, commentary on Edward Stone's 1763 account of willow bark for the ague. Philosophical Transactions of the Royal Society B, 2015. Revisits the report usually treated as the start of the salicylate story. Tier: historical scholarship. Search PubMed
Mahdi JG, on the chemical history of aspirin's discovery from willow. Reviews the salicylate chemistry that meadowsweet shares. Tier: review. Search PubMed

Key Research: Chemistry and Salicylates

Analytical literature on meadowsweet's salicylate glycosides. Characterisation of monotropitin (gaultherin), spiraein and related phenolic glycosides, and their hydrolysis to salicylaldehyde and methyl salicylate. Tier: analytical chemistry. Search PubMed
Savina T and colleagues. "Variation in phenolic compounds, antioxidant and antibacterial activities of extracts from different plant organs of meadowsweet (Filipendula ulmaria)." Molecules, 2023. Documents how much the chemistry differs between flowers, leaves and roots — the analytical reason the dose in a tea cannot be known. Tier: analytical / in vitro. Search PubMed
Vane JR. "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs." Nature New Biology, 1971. The foundational COX mechanism behind every salicylate claim. Tier: established mechanism. Search PubMed
Literature on aspirin's irreversible acetylation of cyclo-oxygenase. The covalent serine modification that distinguishes aspirin from every plant salicylate. Tier: established mechanism. Search PubMed
Willow bark salicin pharmacokinetics. Human studies tracing a plant salicylate glycoside through bacterial hydrolysis to circulating salicylic acid — the same slow, variable route meadowsweet's glycosides take. Tier: human pharmacokinetics (willow). Search PubMed

Key Research: Gastroprotection and Digestion

Samardzic S and colleagues. "Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench." Journal of Ethnopharmacology, 2018. The central modern echo of the traditional gastric use: reduced gastric damage in an experimental model. Tier: preliminary (animal and in vitro). Search PubMed
Early Russian pharmacology on anti-ulcer activity of meadowsweet flower decoction (around 1980). The original animal report behind most modern ulcer claims for this plant. Old, in Russian, predating current reporting standards — provenance rather than reliable evidence. Tier: preliminary (animal), low quality. Search PubMed
Literature on the dual mechanism of NSAID gastric injury. Local ion-trapping injury plus systemic COX-1-dependent loss of mucosal defence — the framework for asking whether a non-acetylated salicylate escapes the problem. Tier: established mechanism. Search PubMed
Comparative gastrointestinal tolerability of non-acetylated salicylates. Salsalate and relatives show less gastric toxicity than aspirin — the strongest drug-based support for meadowsweet's gentler reputation. Tier: clinical pharmacology of drugs, applied by inference. Search PubMed
Tannins, astringency and gastrointestinal effects. Protein binding at mucosal surfaces, anti-diarrhoeal use, and reduced non-haem iron absorption — the honest counterpoint that tannins are not uniformly soothing. Tier: mixed mechanism and human absorption studies. Search PubMed

Key Research: Inflammation, Pain and Antioxidants

Katanic J and colleagues. "In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent." Journal of Ethnopharmacology, 2016. The principal anti-inflammatory study, in both cells and animals. Tier: preliminary (animal and in vitro). Search PubMed
Van der Auwera A and colleagues. "In vitro biotransformation and anti-inflammatory activity of constituents and metabolites of Filipendula ulmaria." Pharmaceutics, 2023. Gut-generated metabolites retain anti-inflammatory activity — important, because the effect then does not require intact glycosides to be absorbed. Tier: preliminary, in vitro. Search PubMed
Recent pharmacology on anti-inflammatory and analgesic effects of Filipendula ulmaria extract in animal models. Adds the pain dimension to the anti-inflammatory picture. Tier: preliminary (animal). Search PubMed
Radulovic N and colleagues. "Antimicrobial synergism and antagonism of salicylaldehyde in Filipendula vulgaris essential oil." Fitoterapia, 2007. Identifies salicylaldehyde as a principal active constituent of the volatile oil. Tier: preliminary, in vitro. Search PubMed
Systematic-review literature on willow bark for musculoskeletal pain. The comparison case: the salicylate herb that does have randomised placebo-controlled trials, showing what meadowsweet's evidence base would look like if it existed. Tier: randomised trials and systematic review (willow bark). Search PubMed
Search for controlled human trials of Filipendula ulmaria. Deliberately included so this site's central negative claim is checkable rather than asserted. Tier: absence of evidence. Search PubMed

Key Research: Salicylate Safety

Reye RD, Morgan G, Baral J. "Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood." Lancet, 1963. The original description of the syndrome behind the paediatric salicylate contraindication. Tier: original clinical description. Search PubMed
Epidemiology of salicylates and Reye's syndrome, and the fall in cases after public health warnings. Surveillance data through the 1980s and 1990s. Tier: epidemiological, strong. Search PubMed
Prevalence meta-analysis of aspirin-exacerbated respiratory disease among people with asthma. Roughly 7% of adults with asthma, with higher rates in severe asthma and in those with nasal polyps. Tier: meta-analysis of prevalence studies. Search PubMed
Guidelines on classification, diagnosis and management of NSAID hypersensitivity. Including the distinction between true allergy and pharmacological cross-intolerance. Tier: expert guideline. Search PubMed
Salicylate–warfarin and salicylate–methotrexate interaction literature. Protein-binding displacement and reduced methotrexate clearance — the mechanistic basis for the drug cautions. Tier: pharmacokinetic and clinical (drugs). Search PubMed
Dicoumarol, spoiled sweet clover and the origin of warfarin. The history showing plain plant coumarin is not an anticoagulant — a myth corrected on the safety page. Tier: established history and pharmacology. Search PubMed

External Resources

PubMed — the biomedical literature database behind every citation search on these pages.
NIH National Center for Complementary and Integrative Health — US government evidence and safety summaries for herbal products.
MedlinePlus — plain-language drug, supplement and condition information from the National Library of Medicine.
European Medicines Agency — the European regulator, whose traditional-use category is where meadowsweet products sit.
DailyMed — official US prescribing information, useful for checking your own medicines' salicylate and NSAID warnings.
Plants of the World Online (Kew) — authoritative record of the Spiraea ulmaria to Filipendula ulmaria name change that the aspirin etymology depends on.

Connections

Safety and disclaimer. Meadowsweet delivers salicylates at an unstandardised, unmeasurable dose. Avoid it if you are sensitive to aspirin or salicylates, if you have aspirin-sensitive asthma or asthma with nasal polyps, if you are pregnant or breastfeeding, or in children and teenagers — especially during a viral illness, because of the Reye's syndrome association with salicylates. Use caution with anticoagulants, antiplatelets, methotrexate and other NSAIDs, and avoid it in active peptic ulcer disease despite the traditional use. These pages are educational information, not medical advice, and nothing here is a reason to stop or change a prescribed medicine — least of all prescribed aspirin. Talk to your doctor or pharmacist before adding a salicylate herb to any treatment.

Back to Table of Contents